At a glance
ClinicalIndex Comparison RecordN/ACompleted· 38 enrolled
Drug / intervention
CorMatrix ECM for Vascular Repairdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Post Market Observational Study on the Use of CorMatrix® ECM® for Femoral Arterial Reconstruction
In Brief
An observational study evaluating CorMatrix ECM for Vascular Repair for Peripheral Vascular Disease. Completed, enrolled 38 participants.
Detailed Summary
To gather information on the use of CorMatrix ECM for Vascular Repair in the reconstruction of the femoral artery.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPeripheral Vascular Disease
Countries--
Collaborators--
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedApr 2015
Enrollment StartMay 2015
Primary CompletionMar 2018
TodayJul 2026
First PostedApr 16, 2015
Enrollment StartMay 1, 2015
Primary CompletionMar 1, 2018
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 11.2 years ago
Interventions
CorMatrix ECM for Vascular Repairdevice
Standard femoral arterial interventional procedure using CorMatrix ECM for vascular repair.